LncRNA SLCO4A1-AS1 inhibits the interaction of β-catenin with GSKβ, inhibits β-catenin phosphorylation, and improves β-catenin stability, ultimately promoting the proliferation, migration, and invasion of CRC cells (82). Here, SLCO4A1 is linked to colorectal carcinoma.